- Home
- UUU vs EVGN Comparison
UUU vs EVGN Comparison
Compare UUU & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- EVGN
- Stock Information
- Founded
- UUU 1969
- EVGN 1999
- Country
- UUU United States
- EVGN Israel
- Employees
- UUU N/A
- EVGN N/A
- Industry
- UUU Electronic Components
- EVGN Agricultural Chemicals
- Sector
- UUU Technology
- EVGN Industrials
- Exchange
- UUU Nasdaq
- EVGN Nasdaq
- Market Cap
- UUU 12.6M
- EVGN 10.9M
- IPO Year
- UUU N/A
- EVGN N/A
- Fundamental
- Price
- UUU $4.90
- EVGN $1.26
- Analyst Decision
- UUU
- EVGN Strong Buy
- Analyst Count
- UUU 0
- EVGN 1
- Target Price
- UUU N/A
- EVGN $3.50
- AVG Volume (30 Days)
- UUU 130.2K
- EVGN 150.6K
- Earning Date
- UUU 11-18-2025
- EVGN 11-20-2025
- Dividend Yield
- UUU 20.41%
- EVGN N/A
- EPS Growth
- UUU N/A
- EVGN N/A
- EPS
- UUU 1.19
- EVGN N/A
- Revenue
- UUU $22,789,285.00
- EVGN $9,444,000.00
- Revenue This Year
- UUU N/A
- EVGN N/A
- Revenue Next Year
- UUU N/A
- EVGN $12.35
- P/E Ratio
- UUU $4.12
- EVGN N/A
- Revenue Growth
- UUU 30.84
- EVGN 42.25
- 52 Week Low
- UUU $1.65
- EVGN $0.95
- 52 Week High
- UUU $8.27
- EVGN $2.87
- Technical
- Relative Strength Index (RSI)
- UUU 47.96
- EVGN 49.79
- Support Level
- UUU $4.64
- EVGN $1.22
- Resistance Level
- UUU $5.79
- EVGN $1.33
- Average True Range (ATR)
- UUU 0.63
- EVGN 0.07
- MACD
- UUU -0.05
- EVGN -0.00
- Stochastic Oscillator
- UUU 12.32
- EVGN 18.27
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.